Literature DB >> 9563708

High seroprevalence of Coxiella burnetii infection in Eastern Cantabria (Spain).

F Pascual-Velasco1, M Montes, J M Marimón, G Cilla.   

Abstract

BACKGROUND: Coxiella burnetii is the causative agent of Q fever, a worldwide zoonosis which shows a wide diversity of clinical manifestations. The objective of this seroepidemiological study was to estimate the prevalence of antibodies to C. burnetii in a representative population of the Eastern area of the Cantabrian Community (Northern Spain).
METHODS: A cross-sectional study was conducted in 595 subjects from Eastern Cantabria. Four different zones (one urban and three rural zones) were defined according to the geographical characteristics of the area and the economic activities of the population. The population sample for this study was collected between December 1994 and March 1995, and was stratified by age, sex and municipality of residence. IgG and IgM antibodies against C. burnetii were assayed by an indirect immunofluorescence technique.
RESULTS: The prevalence of anti-phase II Coxiella IgG (titre > or = 1:16) was 48.6% (95% confidence interval: 44.6-52.6%), with 81.3% havinga titre of > or = 1:64. The prevalence of IgG increased with age, ranging from 12.0% in people < 15 years to 70.3% in those > 65 years (P < 0.001). The antibody detection rate was higher in males (53.6%) than in females (43.3%) (P < 0.01). The prevalence of anti-phase II Coxiella IgG was less among subjects living in the urban zone (32.8%) than in those living in the other three rural zones: the two situated on the coast (54.0% and 54.9% respectively) and the inner mountainous zone (82.3%) (P < 0.001).
CONCLUSIONS: The prevalence of C. burnetii infection observed in this study is one of the highest reported in Europe. The eastern area of Cantabria is a hyperendemic area for Q fever.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563708     DOI: 10.1093/ije/27.1.142

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  10 in total

Review 1.  Q fever in adults: review of 66 clinical cases.

Authors:  M Sampere; B Font; J Font; I Sanfeliu; F Segura
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-18       Impact factor: 3.267

2.  Seroprevalence of Coxiella burnetii antibodies among students of the Faculty of Medicine in Kosice (Slovakia).

Authors:  E Dorko; Z Kalinová; E Pilipcinec
Journal:  Folia Microbiol (Praha)       Date:  2009-04-18       Impact factor: 2.099

3.  Q fever seroprevalence and associated risk factors among students from the Veterinary School of Zaragoza, Spain.

Authors:  M C Valencia; C O Rodriguez; O G Puñet; I de Blas Giral
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

4.  Epidemiological study of Q fever in humans, ruminant animals, and ticks in Cyprus using a geographical information system.

Authors:  A Psaroulaki; C Hadjichristodoulou; F Loukaides; E Soteriades; A Konstantinidis; P Papastergiou; M C Ioannidou; Y Tselentis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

5.  A seroepidemiological study of the risks of Q fever infection in Japanese veterinarians.

Authors:  T Abe; K Yamaki; T Hayakawa; H Fukuda; Y Ito; H Kume; T Komiya; K Ishihara; K Hirai
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

6.  Prevalence of Coxiella burnetii antibodies among febrile patients in Croatia, 2008-2010.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Suncanica Ljubin-Sternak; Branko Kolaric; Bernard Kaic; Lorena Lazaric-Stefanovic; Blazenka Hunjak; Gordana Mlinaric-Galinovic
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-12       Impact factor: 2.133

7.  Seroprevalence of Coxiella burnetii Antibodies Among Ruminants and Occupationally Exposed People in Thailand, 2012-2013.

Authors:  Pawinee Doung-Ngern; Teerasak Chuxnum; Decha Pangjai; Pattarin Opaschaitat; Nattinee Kittiwan; Pranee Rodtian; Noppawan Buameetoop; Gilbert J Kersh; Pawin Padungtod
Journal:  Am J Trop Med Hyg       Date:  2017-01-23       Impact factor: 2.345

8.  Waning population immunity prior to a large Q fever epidemic in the south of The Netherlands.

Authors:  D A H Brandwagt; T Herremans; P M Schneeberger; V H Hackert; C J P A Hoebe; J Paget; W VAN DER Hoek
Journal:  Epidemiol Infect       Date:  2016-04-14       Impact factor: 4.434

Review 9.  [Epidemiology of Q fever in Spain (2018)].

Authors:  J L Pérez-Arellano; C Carranza Rodríguez; C Gutierrez; M Bolaños Rivero
Journal:  Rev Esp Quimioter       Date:  2018-07-19       Impact factor: 1.553

10.  Emergence of q Fever.

Authors:  E Angelakis; D Raoult
Journal:  Iran J Public Health       Date:  2011-09-30       Impact factor: 1.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.